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Communication about sexual problems and sexual
concerns in ovarian cancer: qualitative study
Maxine L Stead, Lesley Fallowfield, Julia M Brown, Peter Selby
The assumption that ovarian cancer and its treatment
(hysterectomy, oophorectomy, and chemotherapy)
have considerable psychosexual effects is reasonable.
Studies in other gynaecological cancers show that
sexual activity is affected and that communication
about this topic is poor.1–4 These issues have been
neglected in ovarian cancer, so this qualitative study
explored its psychosexual impact and the level of com›
munication between women and healthcare profes›
sionals about sexual issues.
Participants, methods, and results
Detailed interviews were conducted with 15 women
with ovarian cancer (median age 56 (range 42›71)
years, median time since diagnosis 18 (8›120) months)
who were identified from a sampling survey as sexually
active or as inactive for reasons related to the
condition. Topics included pre›diagnostic and current
sexual behaviour and response, satisfaction with sex
life, and importance of sex. Interviews were audio›
taped, transcribed verbatim, and analysed using
grounded theory methods,5 starting after the first
interview. Each author read the transcript, noting
themes and issues, and concepts pertaining to similar
issues were grouped into categories. As more
interviews were conducted, a thematic framework of
the categories and their associated themes was
produced, and this was systematically applied to each
transcript, searching for evidence of the categories and
themes. Semistructured interviews were conducted
with the women and 43 clinicians and nurses in Leeds
Belief and reality regarding communication about sexual issues and concerns in patients with
ovarian cancer
Patients’ beliefs
Yes, medical staff should have talked to me about
sexual issues:
• “it would help you understand that it is normal to
feel like I did after the chemo and the operation”
• “I could have understood why I was having sexual
problems if they’d have said ‘you might have problems
sexually because we’ve removed this or that”
• “it would have provided reassurance—light at the
end of the tunnel”
• “you should know what’s going to happen instead of
it hitting you like a tonne of bricks”
Patients’ reality
No, medical staff didn’t talk to me about sexual issues:
• “I didn’t know much about how sex would be
affected, I just had to go through and find out for
myself”
• “you have no idea about how the cancer will affect
you sexually”
• “nobody talks about sex and you wonder whether it
is right that you feel different”
• “the doctor said that if I was having problems with
sex the hospital had creams to help me, but nothing
else was said”
Healthcare professionals’ beliefs
Yes, we should discuss sexual issues with patients:
• “which sexual problems may occur”
• “why sexual problems may occur”
• “reassurance that sexual activity will not cause a
recurrence”
• “reassurance that sexual problems are normal”
• “advice or help is available”
Healthcare professionals’ reality
No, we don’t often discuss sexual issues with patients:
• “it’s not my responsibility”
• “talking about sexual issues is too embarrassing”
• “I’m not sure what types of sexual problems patients
experience”
• “I don’t feel confident talking to patients about sexual
issues”
• “there’s nowhere to talk to patients in private”
• “there’s no time to discuss sexual issues”
• “I wait until a patient asks about sex”
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to determine their attitudes about, and experiences of,
written or verbal communication about sex. Local
research ethics committee approval was granted.
The condition affected women’s sexual desire and
raised fears about sexual activity (for example, fear of
recurrence) and relationship concerns (for example,
fear of rejection). The couple’s ability to discuss sex,
and the woman’s perception that sex maintained
normality or control, contributed to whether or not sex
was resumed. The experience of physical problems (for
example, dyspareunia or vaginal dryness) or psycho›
logical distress affected the continuation of sex, and the
frequency of sexual activity was often reduced. Over
time, physical problems reduced in severity, but the
psychological distress persisted. For some women, sex
never occurred again—the impact on their self esteem
and relationship was devastating. Loss of fertility also
caused distress.
Most women thought that a healthcare profes›
sional should have provided written information or
discussed sexual issues with them. No patient received
written information and only two received brief verbal
information—a medical oncologist told one woman
that the hospital had creams to help if intercourse
proved difficult, and another woman vaguely recalled a
surgeon saying something, but she still felt unsure
about the safety of sexual activity.
The table shows women’s attitudes towards
communication about sexual issues compared with the
reality that they faced. Some women felt uncomfort›
able discussing sex, but they felt that the benefits would
outweigh any embarrassment. Women felt that time
available to discuss psychosexual concerns was limited,
but they did not seek extensive information—
reassurance of the safety of sex, reassurance that their
problems were not unique, and permission to discuss
concerns was often all that was needed.
The table also shows the attitudes and behaviours
of healthcare professionals. All but one thought that
medical staff should discuss psychosexual issues;
however, only four clinicians (25%) and five nurses
(19%) did so. Knowledge about the impact of ovarian
cancer on sexual functioning was lacking, with few
healthcare professionals being aware of the problems
that can occur.
Comment
Ovarian cancer affects sexual functioning, but health›
care professionals’ knowledge about this is inadequate,
as is their communication with patients about sexual
issues. A larger prospective study starting from the
time of diagnosis is planned to identify the prevalence,
duration, and severity of sexual problems in patients
with ovarian cancer.
Healthcare professionals need training to help
them communicate more comfortably about sexual
issues. Detailed discussion may be unnecessary—just a
few reassuring words may be enough to relieve some of
the fears and problems provoked by ovarian cancer
and its treatment.
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A memorable patient
Effective communication
I never met my memorable patient. Indeed, he presented before I
was born and, for all I know, he may have died before I even
graduated. I was a house officer when my father, then a practising
consultant physician and now retired, told me the story of the
patient’s unusual presentation and diagnosis, from some 30 years
previously.
The patient, a tram driver in Liverpool, had been observed to
struggle ineffectually with a simple task while working on the
tramlines immediately outside the city’s Adelphi Hotel. A smartly
dressed stranger came up to the tram driver and presented
him with a slip of paper which had a single word written on it,
and he instructed the man to take the piece of paper to his
doctor. This encounter occurred in the 1950s during a meeting
of the Association of Physicians being held in Liverpool, when
many of the foremost physicians of the time were staying at the
Adelphi Hotel. A few days later, my father happened to be
working in the clinic to which the patient presented, and he
noted the clinical features of puffy face, dry skin, delayed
reflexes, and mental lassitude. A month later, after he started
taking thyroid extract, the life of the patient had been
transformed. The single word on the slip of paper? Myxoedema,
of course.
Why so memorable? I was taught not only the importance of
simple observation in making a diagnosis, but also that the value
of a communication bears little relation to its length.
David Bennett›Jones consultant physician, Cumberland Infirmary,
Carlisle
We welcome articles up to 600 words on topics such as
A memorable patient, A paper that changed my practice,My most
unfortunate mistake,or any other piece conveying instruction,
pathos, or humour. If possible the article should be supplied on a
disk. Permission is needed from the patient or a relative if an
identifiable patient is referred to. We also welcome contributions
for “Endpieces,” consisting of quotations of up to 80 words (but
most are considerably shorter) from any source, ancient or
modern, which have appealed to the reader.
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